FDA

News

FDA okays Merck's would-be Prevnar rival Vaxneuvance

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot.

News

FDA adcomm turns down FibroGen, AZ's roxadustat for CKD anae...

Safety concerns seem to have scuppered any hope of a near-term approval for FibroGen and AstraZeneca's roxadustat for anaemia associated with chronic kidney disease (CKD) in the US, after F

News

Will Gottlieb follow up on Trump's promise of a bonfire of regulations?

FDA staffers defend Aduhelm approval in JAMA editorial

Three FDA figures at the centre of the fallout over the approval Biogen and Eisai's Alzheimer's disease therapy Aduhelm have defended their actions, arguing that to do otherwise would have

News

FDA adds warning of rare neurological side effect to J&J COV...

The FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has been linked to a serious but rare side effect – Guillain-Barré syndrome – that can cause m

News

Bayer's finerenone gets FDA nod for diabetic kidney disease

Bayer's big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in diabetics has paid off with an FDA approval, although it could face stiff compe

News

Aduhelm approval controversy dials up as FDA seeks probe

In another twist to the Aduhelm approval tale, FDA's Janet Woodcock has called for an independent investigation into the relationship between agency staffers and Biogen executives.

FDA okays Merck's would-be Prevnar rival Vaxneuvance

FDA adcomm turns down FibroGen, AZ's roxadustat for CKD anae...

FDA staffers defend Aduhelm approval in JAMA editorial

FDA adds warning of rare neurological side effect to J&J COV...

Bayer's finerenone gets FDA nod for diabetic kidney disease

Aduhelm approval controversy dials up as FDA seeks probe

Third Rock in $2bn drug-hunting pact with China's Funnel

Securing your ROI: Turning post-acquisition integration into...

FDA

Editor's Picks